The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer
Open Access
- 22 June 2018
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 18 (1) , 87
Abstract
Semaphorin 5A has been linked to tumor growth, invasion, and metastasis in pancreatic cancer. However, the role of semaphorin 5A in cervical cancer is not known. Our aim is to investigate the prognostic value of semaphorin 5A and its potential role in lymphangiogenesis and invasion in cervical cancer. In this study, pathological features and clinical data of 232 cervical cancer patients were retrospectively reviewed. Semaphorin 5A protein and mRNA expression was detected by immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction, respectively. In vitro, we determined the role and mechanistic pathways of semaphorin 5A in tumor progression in cervical carcinoma cell lines. Semaphorin 5A expression was significantly higher in stage IIb tumors than in stage Ia, Ib, and IIa tumors. High semaphorin 5A expression was significantly associated with pelvic lymph node metastasis, lymphovascular permeation, and poor survival. Semaphorin 5A induced lymphangiogenesis through a plexin-B/Met/vascular endothelial growth factor-C pathway. Semaphorin 5A also increased cervical cancer cell invasion by stimulating the expression and activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 via PI3K/AKT and plexin-B3. Our findings indicate that semaphorin 5A may represent a poor prognostic biomarker and anti-metastasis therapeutic target in cervical cancer.Keywords
This publication has 48 references indexed in Scilit:
- Semaphorin 5A Promotes Gastric Cancer Invasion/Metastasis via Urokinase-Type Plasminogen Activator/Phosphoinositide 3-Kinase/Protein Kinase BDigestive Diseases and Sciences, 2013
- SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid CancerClinical Cancer Research, 2012
- Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jawsJournal of Oral Pathology & Medicine, 2010
- High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasisInternational Journal of Cancer, 2010
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Molecular Control of Lymphatic MetastasisAnnals of the New York Academy of Sciences, 2008
- PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisCellular Signalling, 2007
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Semaphorins in cancerFrontiers in Bioscience-Landmark, 2005
- The Semaphorin 4D receptor controls invasive growth by coupling with MetNature Cell Biology, 2002